Data / Drug companies / Edenbridge Pharmaceuticals LLC.
Edenbridge Pharmaceuticals LLC.: 37 products in the FDA NDC directory, labeler code 42799
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Edenbridge Pharmaceuticals LLC. (labeler code 42799) lists 37 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 37 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 3, 2026.
The request: Watch Edenbridge Pharmaceuticals LLC. (FDA labeler code 42799): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 42799
- Products in commercial distribution
- 37
- Packages
- 56
- Finished drugs by generic name
- 23
- Prescription products
- 37
- Over the counter products
- 0
- Controlled substance products
- Schedule II 1
- Flagged as original packager
- 37 of 37 products that carry the flag
- Started marketing in the last 12 months
- 4
- Products with a marketing end date set
- 2
- Earliest marketing start
- November 6, 2002
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 31 | 83.8% |
| Other unapproved drugs | 3 | 8.1% |
| Authorized generics (NDA) | 3 | 8.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 37 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Prednisolone sodium phosphate | 4 | 16 |
| Bumetanide | 3 | 42 |
| Isosorbide mononitrate | 3 | 25 |
| Bisoprolol fumarate and hydrochlorothiazide | 3 | 12 |
| Methenamine mandelate | 2 | 5 |
| Etodolac | 2 | 31 |
| Nintedanib | 2 | 11 |
| Tinidazole | 2 | 7 |
| Venlafaxine hydrochloride, extended release | 2 | 1 |
| Loperamide hydrochloride | 1 | 82 |
| Albendazole | 1 | 10 |
| Atropine sulfate | 1 | 24 |
| Ethacrynic acid | 1 | 10 |
| Tofacitinib | 1 | 23 |
| Pantoprazole sodium | 1 | 54 |
| Carbidopa | 1 | 8 |
| Morphine | 1 | 2 |
| Colestipol hydrochloride | 1 | 10 |
| Vigabatrin | 1 | 18 |
| Diclofenac sodium | 1 | 109 |
| Donepezil hydrochloride | 1 | 34 |
| Miglustat | 1 | 7 |
| Ivermectin | 1 | 33 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 15 | 40.5% |
| Tablet, film coated | 6 | 16.2% |
| Capsule | 4 | 10.8% |
| Solution | 4 | 10.8% |
| Tablet, extended release | 4 | 10.8% |
| Solution/ drops | 1 | 2.7% |
| Tablet, film coated, extended release | 1 | 2.7% |
| Granule, delayed release | 1 | 2.7% |
| Tincture | 1 | 2.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tofacitinib | 42799-970 | Tablet, film coated, extended release | Generic drugs (ANDA) | June 3, 2026 |
| Atropine sulfate | 42799-826 | Solution/ drops | Generic drugs (ANDA) | May 6, 2026 |
| Nintedanib | 42799-973 | Capsule | Generic drugs (ANDA) | April 3, 2026 |
| Nintedanib | 42799-972 | Capsule | Generic drugs (ANDA) | April 3, 2026 |
| Colestipol Hydrochloride | 42799-115 | Tablet | Generic drugs (ANDA) | November 26, 2024 |
| Prednisolone Sodium Phosphate | 42799-815 | Solution | Generic drugs (ANDA) | October 9, 2023 |
| Pantoprazole Sodium | 42799-952 | Granule, delayed release | Generic drugs (ANDA) | June 16, 2023 |
| Prednisolone Sodium Phosphate | 42799-816 | Solution | Generic drugs (ANDA) | May 1, 2023 |
| Venlafaxine hydrochloride, extended release | 42799-963 | Tablet | Generic drugs (ANDA) | March 15, 2023 |
| Venlafaxine hydrochloride, extended release | 42799-962 | Tablet | Generic drugs (ANDA) | March 15, 2023 |
| Vigabatrin | 42799-950 | Tablet | Generic drugs (ANDA) | June 29, 2022 |
| Loperamide Hydrochloride | 42799-605 | Capsule | Generic drugs (ANDA) | September 25, 2020 |
| Yargesa | 42799-709 | Capsule | Generic drugs (ANDA) | August 6, 2020 |
| Tinidazole | 42799-208 | Tablet | Generic drugs (ANDA) | December 20, 2019 |
| Tinidazole | 42799-207 | Tablet | Generic drugs (ANDA) | December 20, 2019 |
| Albendazole | 42799-110 | Tablet | Generic drugs (ANDA) | May 17, 2019 |
| Bisoprolol Fumarate and Hydrochlorothiazide | 42799-922 | Tablet, film coated | Generic drugs (ANDA) | April 30, 2019 |
| Bisoprolol Fumarate and Hydrochlorothiazide | 42799-921 | Tablet, film coated | Generic drugs (ANDA) | April 30, 2019 |
| Bisoprolol Fumarate and Hydrochlorothiazide | 42799-920 | Tablet, film coated | Generic drugs (ANDA) | April 30, 2019 |
| Etodolac | 42799-112 | Tablet, film coated | Generic drugs (ANDA) | December 7, 2018 |
| Etodolac | 42799-111 | Tablet, film coated | Generic drugs (ANDA) | December 7, 2018 |
| Isosorbide Mononitrate | 42799-960 | Tablet, extended release | Generic drugs (ANDA) | November 15, 2018 |
| Isosorbide Mononitrate | 42799-958 | Tablet, extended release | Generic drugs (ANDA) | January 5, 2017 |
| Ethacrynic Acid | 42799-405 | Tablet | Generic drugs (ANDA) | July 1, 2016 |
| Donepezil hydrochloride | 42799-954 | Tablet, film coated | Generic drugs (ANDA) | February 19, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.